Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 491-54-3 Chemical Structure| 491-54-3

Structure of Kaempferide
CAS No.: 491-54-3

Chemical Structure| 491-54-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Kaempferide is an O-methylated flavonol that purified from the root of Kaempferia galangal L. and can be used as an antihypertensive agent.

Synonyms: Kaempferol 4'-O-methyl ether;NSC 407294;Kaempferol 4'-methyl ether

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Kaempferide

CAS No. :491-54-3
Formula : C16H12O6
M.W : 300.26
SMILES Code : O=C1C(O)=C(C2=CC=C(OC)C=C2)OC3=C1C(O)=CC(O)=C3
Synonyms :
Kaempferol 4'-O-methyl ether;NSC 407294;Kaempferol 4'-methyl ether
English Name :3,5,7-Trihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one
MDL No. :MFCD00016771
InChI Key :SQFSKOYWJBQGKQ-UHFFFAOYSA-N
Pubchem ID :5281666

Safety of Kaempferide

Related Pathways of Kaempferide

RTK
PI3K-AKT
JAK-STAT
Hedgehog

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HK-2 cells 10 μM 24 hours Kaempferide significantly inhibited cisplatin-induced injuries in HK-2 cells, reducing apoptosis and oxidative stress. Acta Pharmacol Sin. 2023 Jul;44(7):1442-1454
HepG2 cells 5, 10, 20 µM 48 hours Kaempferide attenuated OA-induced lipid accumulation and oxidative stress in HepG2 cells, reduced the accumulation of intracellular lipid droplets and TG levels, and decreased expression of SREBP1, FAS and SCD-1. Int J Mol Sci. 2021 Aug 17;22(16):8847
human lung adenocarcinoma A549 cells 10 μM 6 hours Kaempferide decreased the mRNA level and promoter activity of CLDN2. Nutrients. 2020 Apr 23;12(4):1190
human lung adenocarcinoma A549 cells 1-50 μM 24 hours Kaempferide dose-dependently decreased CLDN2 expression without affecting cell viability. Nutrients. 2020 Apr 23;12(4):1190
NIH-3T3 cells 2.5 μM and 5 μM 24 hours To evaluate the inhibitory effect of KFD on UVB-induced ROS generation, results showed that KFD dose-dependently inhibited UVB-induced ROS overproduction. Antioxidants (Basel). 2022 Dec 21;12(1):11
H9c2 cardiomyocytes 50 μM 1 hour Kaempferide reduced DOX-induced 53BP1 aggregation and ameliorated the decrease in ATP levels in H9c2 cardiomyocytes Biol Direct. 2023 Oct 9;18(1):63
3T3-L1 cells 20 µM 24 hours Kaem promoted autophagy flux in 3T3-L1 adipocytes, reducing lipid droplet accumulation, indicating its role in lipid metabolism. Commun Biol. 2021 Jan 4;4(1):1
HeLa cells 20 µM 24 hours Kaem enhanced lysosomal acidity, increased LC3-II conversion, and reduced p62 protein levels, indicating enhanced autophagy. Commun Biol. 2021 Jan 4;4(1):1

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Cisplatin-induced acute kidney injury model Oral 50 mg/kg Continuous for 5 days Kaempferide significantly improved renal function, ameliorated renal tissue damage, inhibited oxidative stress, and induced autophagy. Acta Pharmacol Sin. 2023 Jul;44(7):1442-1454
C57BL/6j mice High-fat diet-induced obesity model Intraperitoneal injection 10 mg/kg Every 2 days for 2 months Kaem treatment significantly reduced body weight gain, improved non-fasting blood glucose levels, and reduced hepatic steatosis in high-fat diet-induced obese mice. Commun Biol. 2021 Jan 4;4(1):1
C57BL/6 mice UVB-induced photoaging model Topical application 250 μM and 500 μM Every other day for 10 weeks To evaluate the inhibitory effect of KFD on UVB-induced wrinkle formation and epidermal thickening in mice skin, results showed that KFD significantly reduced the number of wrinkles and epidermal thickness. Antioxidants (Basel). 2022 Dec 21;12(1):11
Sprague Dawley (SD) rats Myocardial ischemia/reperfusion injury model Intraperitoneal injection Low dose (0.1 mg/kg), moderate dose (0.3 mg/kg), high dose (1 mg/kg) Single dose, 30 min prior to ischemia Kaempferide significantly improved cardiac function, alleviated myocardial injury, reduced myocardial infarct size in a dose-dependent manner. Additionally, Kaempferide significantly decreased serum TNF-α, IL-6, C-reactive protein (CRP), MDA, and ROS levels, while increasing serum SOD levels. Mediators Inflamm. 2017;2017:5278218

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.33mL

0.67mL

0.33mL

16.65mL

3.33mL

1.67mL

33.30mL

6.66mL

3.33mL

References

 

Historical Records

Categories